help button home button Am J Pathol ASIP MEMBERSHIP
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Originally published online as doi:10.2353/ajpath.2008.070862 on December 28, 2007 Originally published online as doi:10.2353/ajpath.2008.070862 on December 6, 2007

Published online before print December 6, 2007
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
ajpath.2008.070862v1
ajpath.2008.070862v2
172/1/8    most recent
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Google Scholar
Right arrow Articles by Gold, R.
Right arrow Articles by Lühder, F.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gold, R.
Right arrow Articles by Lühder, F.
(American Journal of Pathology. 2008;172:8-10.)
© 2008 American Society for Investigative Pathology
DOI: 10.2353/ajpath.2008.070862

Commentary

Interleukin-17—Extended Features of a Key Player in Multiple Sclerosis

Ralf Gold, M.D.* and Fred Lühder, Ph.D.{dagger}

From the Department of Neurology,*University of Bochum, Bochum, Germany; and the Institute for Multiple Sclerosis Research,{dagger}University of Goettingen, Goettingen, Germany

Abstract

Interleukin-17 has recently joined the club of molecules considered as important immunological players for inflammation in the nervous system, as discussed in this Commentary.






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2008 by the American Society for Investigative Pathology.